{"transactions":[{"id":689962,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to purchase)","published_at":"2026-08-12T20:12:49.000Z","date":"2026-08-11","kind":"exercise","planned":true,"acquired":false,"shares":13353,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All shares of Axogen, Inc. common stock underlying the board of director's stock option were fully vested on May 14, 2018."}],"balance_after":0,"derivative":{"exercise_price":14.85,"expiration_date":"2027-06-01","underlying":"Common Stock","underlying_shares":13353},"source":{"system":"sec-edgar","filing":"0000805928-26-000098","document":"wk-form4_1786565567.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000098/wk-form4_1786565567.xml","form_type":"4"}},{"id":689961,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-12T20:12:49.000Z","date":"2026-08-11","kind":"sale","planned":true,"acquired":false,"shares":13353,"price":48.423,"value":646592.319,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on the this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on May 12, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $47.82 to $49.02 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":107976,"source":{"system":"sec-edgar","filing":"0000805928-26-000098","document":"wk-form4_1786565567.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000098/wk-form4_1786565567.xml","form_type":"4"}},{"id":689960,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-12T20:12:49.000Z","date":"2026-08-11","kind":"exercise","planned":true,"acquired":true,"shares":13353,"price":14.85,"value":198292.05,"ownership":{"direct":true},"balance_after":121329,"source":{"system":"sec-edgar","filing":"0000805928-26-000098","document":"wk-form4_1786565567.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000098/wk-form4_1786565567.xml","form_type":"4"}},{"id":725984,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-26T20:52:22.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":4392,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $185,000 valuation as of the grant date and vests on June 24, 2027, the one-year anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $185,000 valuation as of the grant date and vests on June 24, 2027, the one-year anniversary of the grant date."}],"balance_after":4392,"derivative":{"underlying":"Common Stock","underlying_shares":4392},"source":{"system":"sec-edgar","filing":"0001400568-26-000015","document":"wk-form4_1782507140.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000140056826000015/wk-form4_1782507140.xml","form_type":"4"}},{"id":729767,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-23T20:36:41.000Z","date":"2026-06-19","kind":"exercise","planned":false,"acquired":true,"shares":14150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on June 19, 2026, the one-year anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on June 19, 2026, the one-year anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":14150},"source":{"system":"sec-edgar","filing":"0001400568-26-000013","document":"wk-form4_1782246998.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000140056826000013/wk-form4_1782246998.xml","form_type":"4"}},{"id":729766,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-23T20:36:41.000Z","date":"2026-06-19","kind":"exercise","planned":false,"acquired":true,"shares":14150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of restricted stock units that vested June 19, 2026."}],"balance_after":107976,"source":{"system":"sec-edgar","filing":"0001400568-26-000013","document":"wk-form4_1782246998.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000140056826000013/wk-form4_1782246998.xml","form_type":"4"}},{"id":774775,"issuer":{"id":1645,"kind":"organization","name":"Solventum Corp","symbol":"SOLV"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-18T21:35:51.000Z","date":"2026-05-15","kind":"grant","planned":false,"acquired":true,"shares":3300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock unit (\"RSU\") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs shall fully vest on May 15, 2027, subject to continued service through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs shall fully vest on May 15, 2027, subject to continued service through the vesting date."}],"balance_after":3300,"derivative":{"underlying":"Common Stock","underlying_shares":3300},"source":{"system":"sec-edgar","filing":"0001400568-26-000011","document":"wk-form4_1779140149.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1400568/000140056826000011/wk-form4_1779140149.xml","form_type":"4"}},{"id":783522,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to purchase)","published_at":"2026-05-12T20:06:30.000Z","date":"2026-05-08","kind":"exercise","planned":false,"acquired":false,"shares":1647,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All shares of Axogen, Inc. common stock underlying the board of director's stock option were fully vested on May 31, 2018."}],"balance_after":13353,"derivative":{"exercise_price":14.85,"expiration_date":"2027-06-01","underlying":"Common Stock","underlying_shares":1647},"source":{"system":"sec-edgar","filing":"0001400568-26-000009","document":"wk-form4_1778616387.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000140056826000009/wk-form4_1778616387.xml","form_type":"4"}},{"id":783521,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-12T20:06:30.000Z","date":"2026-05-08","kind":"sale","planned":false,"acquired":false,"shares":1647,"price":42.6,"value":70162.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $42.50 to $42.62 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":93826,"source":{"system":"sec-edgar","filing":"0001400568-26-000009","document":"wk-form4_1778616387.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000140056826000009/wk-form4_1778616387.xml","form_type":"4"}},{"id":783520,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-12T20:06:30.000Z","date":"2026-05-08","kind":"exercise","planned":false,"acquired":true,"shares":1647,"price":14.85,"value":24457.95,"ownership":{"direct":true},"balance_after":95473,"source":{"system":"sec-edgar","filing":"0001400568-26-000009","document":"wk-form4_1778616387.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000140056826000009/wk-form4_1778616387.xml","form_type":"4"}},{"id":789341,"issuer":{"id":1707,"kind":"organization","name":"BAXTER INTERNATIONAL INC","symbol":"BAX"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $1 par value","published_at":"2026-05-07T20:21:08.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":12836,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Total includes the automatic reinvestment of dividends."}],"balance_after":44235,"source":{"system":"sec-edgar","filing":"0001628280-26-032190","document":"wk-form4_1778185265.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/10456/000162828026032190/wk-form4_1778185265.xml","form_type":"4"}},{"id":795502,"issuer":{"id":1645,"kind":"organization","name":"Solventum Corp","symbol":"SOLV"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-01T20:31:18.000Z","date":"2026-04-30","kind":"exercise","planned":false,"acquired":false,"shares":3403,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock unit (\"RSU\") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs are fully vested."}],"balance_after":0,"derivative":{"expiration_date":"2035-04-30","underlying":"Common Stock","underlying_shares":3403},"source":{"system":"sec-edgar","filing":"0001400568-26-000007","document":"wk-form4_1777667475.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1400568/000140056826000007/wk-form4_1777667475.xml","form_type":"4"}},{"id":795501,"issuer":{"id":1645,"kind":"organization","name":"Solventum Corp","symbol":"SOLV"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-01T20:31:18.000Z","date":"2026-04-30","kind":"exercise","planned":false,"acquired":true,"shares":3403,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10422,"source":{"system":"sec-edgar","filing":"0001400568-26-000007","document":"wk-form4_1777667475.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1400568/000140056826000007/wk-form4_1777667475.xml","form_type":"4"}},{"id":812001,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2026-04-09T21:20:57.000Z","date":"2026-04-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5535,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"For Footnote (3), see Remarks below."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"For Footnote (3), see Remarks below."}],"balance_after":0,"derivative":{"exercise_price":64.36,"expiration_date":"2035-02-26","underlying":"Common Stock","underlying_shares":5535},"source":{"system":"sec-edgar","filing":"0000859737-26-000077","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/859737/000085973726000077/form4.xml","form_type":"4"}},{"id":812000,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2026-04-09T21:20:57.000Z","date":"2026-04-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":4536,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"For Footnote (3), see Remarks below."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"For Footnote (3), see Remarks below."}],"balance_after":0,"derivative":{"exercise_price":76.32,"expiration_date":"2034-03-07","underlying":"Common Stock","underlying_shares":4536},"source":{"system":"sec-edgar","filing":"0000859737-26-000077","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/859737/000085973726000077/form4.xml","form_type":"4"}},{"id":811999,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2026-04-09T21:20:57.000Z","date":"2026-04-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":4210,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"For Footnote (3), see Remarks below."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"For Footnote (3), see Remarks below."}],"balance_after":0,"derivative":{"exercise_price":78.49,"expiration_date":"2033-03-09","underlying":"Common Stock","underlying_shares":4210},"source":{"system":"sec-edgar","filing":"0000859737-26-000077","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/859737/000085973726000077/form4.xml","form_type":"4"}},{"id":811998,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2026-04-09T21:20:57.000Z","date":"2026-04-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5293,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"For Footnote (3), see Remarks below."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"For Footnote (3), see Remarks below."}],"balance_after":0,"derivative":{"exercise_price":70.28,"expiration_date":"2032-03-10","underlying":"Common Stock","underlying_shares":5293},"source":{"system":"sec-edgar","filing":"0000859737-26-000077","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/859737/000085973726000077/form4.xml","form_type":"4"}},{"id":811997,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2026-04-09T21:20:57.000Z","date":"2026-04-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5055,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"For Footnote (3), see Remarks below."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"For Footnote (3), see Remarks below."}],"balance_after":0,"derivative":{"exercise_price":71.03,"expiration_date":"2031-03-11","underlying":"Common Stock","underlying_shares":5055},"source":{"system":"sec-edgar","filing":"0000859737-26-000077","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/859737/000085973726000077/form4.xml","form_type":"4"}},{"id":811996,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2026-04-09T21:20:57.000Z","date":"2026-04-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":7322,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"For Footnote (3), see Remarks below."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"For Footnote (3), see Remarks below."}],"balance_after":0,"derivative":{"exercise_price":47.36,"expiration_date":"2030-03-05","underlying":"Common Stock","underlying_shares":7322},"source":{"system":"sec-edgar","filing":"0000859737-26-000077","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/859737/000085973726000077/form4.xml","form_type":"4"}},{"id":811995,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2026-04-09T21:20:57.000Z","date":"2026-04-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":6523,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"For Footnote (3), see Remarks below."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"For Footnote (3), see Remarks below."}],"balance_after":0,"derivative":{"exercise_price":46.81,"expiration_date":"2029-03-07","underlying":"Common Stock","underlying_shares":6523},"source":{"system":"sec-edgar","filing":"0000859737-26-000077","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/859737/000085973726000077/form4.xml","form_type":"4"}},{"id":811994,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2026-04-09T21:20:57.000Z","date":"2026-04-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":7551,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"For Footnote (3), see Remarks below."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"For Footnote (3), see Remarks below."}],"balance_after":0,"derivative":{"exercise_price":38.44,"expiration_date":"2028-03-14","underlying":"Common Stock","underlying_shares":7551},"source":{"system":"sec-edgar","filing":"0000859737-26-000077","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/859737/000085973726000077/form4.xml","form_type":"4"}},{"id":811993,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2026-04-09T21:20:57.000Z","date":"2026-04-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":6816,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"For Footnote (3), see Remarks below."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"For Footnote (3), see Remarks below."}],"balance_after":0,"derivative":{"exercise_price":41.92,"expiration_date":"2027-03-08","underlying":"Common Stock","underlying_shares":6816},"source":{"system":"sec-edgar","filing":"0000859737-26-000077","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/859737/000085973726000077/form4.xml","form_type":"4"}},{"id":811992,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2026-04-09T21:20:57.000Z","date":"2026-04-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"For Footnote (3), see Remarks below."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"For Footnote (3), see Remarks below."}],"balance_after":0,"derivative":{"exercise_price":40.79,"expiration_date":"2026-12-14","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0000859737-26-000077","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/859737/000085973726000077/form4.xml","form_type":"4"}},{"id":811991,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-04-09T21:20:57.000Z","date":"2026-04-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":25784,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 21, 2025 (the \"Merger Agreement\"), by and among Hologic, Inc. (\"Hologic\" or \"Company\"), Hopper Parent Inc., a Delaware corporation (\"Parent\"), and Hopper Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of Parent (\"Merger Sub\"), Merger Sub merged with and into the Company (the \"Merger\"), with the Company surviving the Merger as a wholly owned subsidiary of Parent.  At the effective time of the Merger (the \"Effective Time\"), each share of Hologic common stock, par value $0.01 (\"Company Common Stock\"), was converted into the right to receive (x) $76.00 per share in cash, without interest (the \"Cash Consideration\") and (y) one (1) contingent value right, which represents the right to receive up to $3.00 in cash, when and if payable (each, a \"CVR\") (the consideration contemplated by clauses (x) and (y), together, the \"Merger Consideration\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the Effective Time, each time-vesting restricted stock unit award (a \"Company RSU Award\") held directly by the reporting person was converted into the right to receive the Merger Consideration in respect of each share of Company Common Stock underlying the Company RSU Award. As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Company Common Stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000859737-26-000077","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/859737/000085973726000077/form4.xml","form_type":"4"}},{"id":825179,"issuer":{"id":1645,"kind":"organization","name":"Solventum Corp","symbol":"SOLV"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-03-30T23:38:12.000Z","date":"2026-03-27","kind":"exercise","planned":false,"acquired":false,"shares":1980,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs are fully vested."}],"balance_after":0,"derivative":{"expiration_date":"2034-05-13","underlying":"Common Stock","underlying_shares":1980},"source":{"system":"sec-edgar","filing":"0001400568-26-000004","document":"wk-form4_1774913889.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1400568/000140056826000004/wk-form4_1774913889.xml","form_type":"4"}},{"id":825178,"issuer":{"id":1645,"kind":"organization","name":"Solventum Corp","symbol":"SOLV"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-30T23:38:12.000Z","date":"2026-03-27","kind":"exercise","planned":false,"acquired":true,"shares":1980,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7019,"source":{"system":"sec-edgar","filing":"0001400568-26-000004","document":"wk-form4_1774913889.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1400568/000140056826000004/wk-form4_1774913889.xml","form_type":"4"}},{"id":848543,"issuer":{"id":1645,"kind":"organization","name":"Solventum Corp","symbol":"SOLV"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-11T10:31:11.000Z","date":"2026-03-10","kind":"purchase","planned":false,"acquired":true,"shares":1475,"price":68.03,"value":100344.25,"ownership":{"direct":true},"balance_after":5039,"source":{"system":"sec-edgar","filing":"0001400568-26-000002","document":"wk-form4_1773225067.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1400568/000140056826000002/wk-form4_1773225067.xml","form_type":"4"}},{"id":875590,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-03-02T21:29:04.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":3190,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units which vest on the date of the 2027 Annual Meeting of Stockholders and are settled in shares of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units are settled in shares of common stock on a one-for-one basis."}],"balance_after":25784,"source":{"system":"sec-edgar","filing":"0000859737-26-000031","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/859737/000085973726000031/form4.xml","form_type":"4"}},{"id":966164,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2025-12-17T21:25:23.000Z","date":"2025-12-16","kind":"exercise","planned":false,"acquired":false,"shares":18248,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Board of Directors' non-qualified stock option grant that vested in full June 6, 2025."}],"balance_after":0,"derivative":{"exercise_price":7.04,"expiration_date":"2034-06-06","underlying":"Common Stock","underlying_shares":18248},"source":{"system":"sec-edgar","filing":"0001400568-25-000005","document":"wk-form4_1766006718.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/805928/000140056825000005/wk-form4_1766006718.xml","form_type":"4"}},{"id":966163,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2025-12-17T21:25:23.000Z","date":"2025-12-16","kind":"exercise","planned":false,"acquired":false,"shares":20436,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Board of Directors' non-qualified stock option grant that vested in full September 1, 2024."}],"balance_after":0,"derivative":{"exercise_price":6.3,"expiration_date":"2033-09-01","underlying":"Common Stock","underlying_shares":20436},"source":{"system":"sec-edgar","filing":"0001400568-25-000005","document":"wk-form4_1766006718.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/805928/000140056825000005/wk-form4_1766006718.xml","form_type":"4"}},{"id":966162,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2025-12-17T21:25:23.000Z","date":"2025-12-16","kind":"exercise","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Board of Directors' non-qualified stock option grant that vested in full May 26, 2017."}],"balance_after":0,"derivative":{"exercise_price":8.95,"expiration_date":"2026-12-29","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001400568-25-000005","document":"wk-form4_1766006718.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/805928/000140056825000005/wk-form4_1766006718.xml","form_type":"4"}},{"id":966161,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-17T21:25:23.000Z","date":"2025-12-16","kind":"sale","planned":false,"acquired":false,"shares":18248,"price":29.312,"value":534885.376,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $28.99 to $29.63 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":93826,"source":{"system":"sec-edgar","filing":"0001400568-25-000005","document":"wk-form4_1766006718.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/805928/000140056825000005/wk-form4_1766006718.xml","form_type":"4"}},{"id":966160,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-17T21:25:23.000Z","date":"2025-12-16","kind":"sale","planned":false,"acquired":false,"shares":20436,"price":29.312,"value":599020.032,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $28.99 to $29.63 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":112074,"source":{"system":"sec-edgar","filing":"0001400568-25-000005","document":"wk-form4_1766006718.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/805928/000140056825000005/wk-form4_1766006718.xml","form_type":"4"}},{"id":966159,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-17T21:25:23.000Z","date":"2025-12-16","kind":"sale","planned":false,"acquired":false,"shares":5000,"price":29.312,"value":146560.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $28.99 to $29.63 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":132510,"source":{"system":"sec-edgar","filing":"0001400568-25-000005","document":"wk-form4_1766006718.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/805928/000140056825000005/wk-form4_1766006718.xml","form_type":"4"}},{"id":966158,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-17T21:25:23.000Z","date":"2025-12-16","kind":"exercise","planned":false,"acquired":true,"shares":18248,"price":7.04,"value":128465.92,"ownership":{"direct":true},"balance_after":137510,"source":{"system":"sec-edgar","filing":"0001400568-25-000005","document":"wk-form4_1766006718.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000140056825000005/wk-form4_1766006718.xml","form_type":"4"}},{"id":966157,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-17T21:25:23.000Z","date":"2025-12-16","kind":"exercise","planned":false,"acquired":true,"shares":20436,"price":6.3,"value":128746.8,"ownership":{"direct":true},"balance_after":119262,"source":{"system":"sec-edgar","filing":"0001400568-25-000005","document":"wk-form4_1766006718.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000140056825000005/wk-form4_1766006718.xml","form_type":"4"}},{"id":966156,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-17T21:25:23.000Z","date":"2025-12-16","kind":"exercise","planned":false,"acquired":true,"shares":5000,"price":8.95,"value":44750.0,"ownership":{"direct":true},"balance_after":98826,"source":{"system":"sec-edgar","filing":"0001400568-25-000005","document":"wk-form4_1766006718.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000140056825000005/wk-form4_1766006718.xml","form_type":"4"}},{"id":1105640,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-20T20:09:51.000Z","date":"2025-06-19","kind":"grant","planned":false,"acquired":true,"shares":14150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on June 19, 2026, the one-year anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on June 19, 2026, the one-year anniversary of the grant date."}],"balance_after":14150,"derivative":{"underlying":"Common Stock","underlying_shares":14150},"source":{"system":"sec-edgar","filing":"0000805928-25-000100","document":"wk-form4_1750450184.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000100/wk-form4_1750450184.xml","form_type":"4"}},{"id":1115739,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-11T20:26:03.000Z","date":"2025-06-09","kind":"sale","planned":false,"acquired":false,"shares":4073,"price":10.61,"value":43214.53,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported price in Column 4 is a weighted average sale price. These shares were sold on June 9, 2025 in multiple transactions at prices ranging from $10.47 to $10.61 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units."}],"balance_after":93826,"source":{"system":"sec-edgar","filing":"0000805928-25-000084","document":"wk-form4_1749673557.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000084/wk-form4_1749673557.xml","form_type":"4"}},{"id":1147222,"issuer":{"id":1645,"kind":"organization","name":"Solventum Corp","symbol":"SOLV"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-05-15T20:22:01.000Z","date":"2025-05-13","kind":"exercise","planned":false,"acquired":false,"shares":3564,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive 1 share of the issuer's Class A Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs fully vested on May 13, 2025."}],"balance_after":0,"derivative":{"expiration_date":"2034-05-13","underlying":"Common Stock","underlying_shares":3564},"source":{"system":"sec-edgar","filing":"0001628280-25-025956","document":"wk-form4_1747340508.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1400568/000162828025025956/wk-form4_1747340508.xml","form_type":"4"}},{"id":1147221,"issuer":{"id":1645,"kind":"organization","name":"Solventum Corp","symbol":"SOLV"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-15T20:22:01.000Z","date":"2025-05-13","kind":"exercise","planned":false,"acquired":true,"shares":3564,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3564,"source":{"system":"sec-edgar","filing":"0001628280-25-025956","document":"wk-form4_1747340508.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1400568/000162828025025956/wk-form4_1747340508.xml","form_type":"4"}},{"id":1155844,"issuer":{"id":1707,"kind":"organization","name":"BAXTER INTERNATIONAL INC","symbol":"BAX"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $1 par value","published_at":"2025-05-08T20:28:59.000Z","date":"2025-05-06","kind":"grant","planned":false,"acquired":true,"shares":7183,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Total includes the automatic reinvestment of dividends."}],"balance_after":31222,"source":{"system":"sec-edgar","filing":"0001062993-25-008904","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/10456/000106299325008904/form4.xml","form_type":"4"}},{"id":1161034,"issuer":{"id":1645,"kind":"organization","name":"Solventum Corp","symbol":"SOLV"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-05-02T20:16:21.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":3403,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock unit (\"RSU\") represents a contingent right to receive 1 share of the issuer's Class A Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs shall fully vest on April 30, 2026, subject to continued service through the vesting date."}],"balance_after":3403,"derivative":{"expiration_date":"2025-04-30","underlying":"Common Stock","underlying_shares":3403},"source":{"system":"sec-edgar","filing":"0001628280-25-021842","document":"wk-form4_1746216974.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1400568/000162828025021842/wk-form4_1746216974.xml","form_type":"4"}},{"id":1224730,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-05T23:20:11.000Z","date":"2025-03-03","kind":"sale","planned":false,"acquired":false,"shares":5000,"price":20.02,"value":100100.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were sold pursuant to an Approved Rule 10b5-1 Plan, as defined under the Company's Insider Trading Policy."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $19.91 to $20.15 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":97899,"source":{"system":"sec-edgar","filing":"0000805928-25-000034","document":"wk-form4_1741216805.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000034/wk-form4_1741216805.xml","form_type":"4"}},{"id":1239613,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2025-02-28T21:29:40.000Z","date":"2025-02-26","kind":"grant","planned":false,"acquired":true,"shares":5535,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options become exercisable on the date of the 2026 Annual Meeting of Stockholders."}],"balance_after":5535,"derivative":{"exercise_price":64.36,"expiration_date":"2035-02-26","underlying":"Common Stock","underlying_shares":5535},"source":{"system":"sec-edgar","filing":"0001127602-25-007276","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760225007276/form4.xml","form_type":"4"}},{"id":1239612,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-02-28T21:29:40.000Z","date":"2025-02-26","kind":"grant","planned":false,"acquired":true,"shares":1864,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units which vest on the date of the 2026 Annual Meeting of Stockholders and are settled in shares of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units are settled in shares of common stock on a one-for-one basis."}],"balance_after":22594,"source":{"system":"sec-edgar","filing":"0001127602-25-007276","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760225007276/form4.xml","form_type":"4"}},{"id":1416925,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-09-04T21:18:07.000Z","date":"2024-09-01","kind":"exercise","planned":false,"acquired":false,"shares":11904,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on September 1, 2024, one year anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on September 1, 2024, one year anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":11904},"source":{"system":"sec-edgar","filing":"0000805928-24-000114","document":"wk-form4_1725482772.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592824000114/wk-form4_1725482772.xml","form_type":"4"}},{"id":1416924,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-04T21:18:07.000Z","date":"2024-09-01","kind":"exercise","planned":false,"acquired":true,"shares":11904,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of restricted stock units that vested on September 1,  2024."}],"balance_after":102899,"source":{"system":"sec-edgar","filing":"0000805928-24-000114","document":"wk-form4_1725482772.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592824000114/wk-form4_1725482772.xml","form_type":"4"}},{"id":1485719,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2024-06-10T22:24:08.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":18248,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on June 6, 2025, one year from the anniversary of the grant date. One-half of the annual equity grant is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units."}],"balance_after":18248,"derivative":{"exercise_price":7.04,"expiration_date":"2034-06-06","underlying":"Common Stock","underlying_shares":18248},"source":{"system":"sec-edgar","filing":"0000805928-24-000103","document":"wk-form4_1718058239.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592824000103/wk-form4_1718058239.xml","form_type":"4"}},{"id":1485718,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-10T22:24:08.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":10653,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."}],"balance_after":90995,"source":{"system":"sec-edgar","filing":"0000805928-24-000103","document":"wk-form4_1718058239.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592824000103/wk-form4_1718058239.xml","form_type":"4"}},{"id":1515821,"issuer":{"id":1645,"kind":"organization","name":"Solventum Corp","symbol":"SOLV"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2024-05-15T20:35:19.000Z","date":"2024-05-13","kind":"grant","planned":false,"acquired":true,"shares":1980,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock unit (\"RSU\") represents a contingent right to receive 1 share of the issuer's Class A Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall fully vest on March 27, 2026, subject to continued service through the vesting date."}],"balance_after":5544,"derivative":{"expiration_date":"2034-05-13","underlying":"Common Stock","underlying_shares":1980},"source":{"system":"sec-edgar","filing":"0001127602-24-015465","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1400568/000112760224015465/form4.xml","form_type":"4"}},{"id":1515820,"issuer":{"id":1645,"kind":"organization","name":"Solventum Corp","symbol":"SOLV"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2024-05-15T20:35:19.000Z","date":"2024-05-13","kind":"grant","planned":false,"acquired":true,"shares":3564,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock unit (\"RSU\") represents a contingent right to receive 1 share of the issuer's Class A Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs shall fully vest on May 13, 2025, subject to continued service through the vesting date."}],"balance_after":3564,"derivative":{"expiration_date":"2034-05-13","underlying":"Common Stock","underlying_shares":3564},"source":{"system":"sec-edgar","filing":"0001127602-24-015465","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1400568/000112760224015465/form4.xml","form_type":"4"}},{"id":1522896,"issuer":{"id":1707,"kind":"organization","name":"BAXTER INTERNATIONAL INC","symbol":"BAX"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $1 par value","published_at":"2024-05-09T20:35:49.000Z","date":"2024-05-07","kind":"grant","planned":false,"acquired":true,"shares":5952,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Total includes the automatic reinvestment of dividends."}],"balance_after":23876,"source":{"system":"sec-edgar","filing":"0001062993-24-009787","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/10456/000106299324009787/form4.xml","form_type":"4"}},{"id":1585340,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2024-03-11T22:11:36.000Z","date":"2024-03-07","kind":"grant","planned":false,"acquired":true,"shares":4536,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options become exercisable on the date of the 2025 Annual Meeting of Stockholders."}],"balance_after":4536,"derivative":{"exercise_price":76.32,"expiration_date":"2034-03-07","underlying":"Common Stock","underlying_shares":4536},"source":{"system":"sec-edgar","filing":"0001127602-24-009458","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760224009458/form4.xml","form_type":"4"}},{"id":1585339,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-03-11T22:11:36.000Z","date":"2024-03-07","kind":"grant","planned":false,"acquired":true,"shares":1572,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units which vest on the date of the 2025 Annual Meeting of Stockholders and are settled in shares of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units are settled in shares of common stock on a one-for-one basis."}],"balance_after":20730,"source":{"system":"sec-edgar","filing":"0001127602-24-009458","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760224009458/form4.xml","form_type":"4"}},{"id":1785251,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-08T20:20:24.000Z","date":"2023-09-06","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":6.224,"value":62240.0,"ownership":{"direct":true},"balance_after":80342,"source":{"system":"sec-edgar","filing":"0000805928-23-000124","document":"wf-form4_169420440642854.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000124/wf-form4_169420440642854.xml","form_type":"4"}},{"id":1786370,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-09-07T10:34:48.000Z","date":"2023-09-01","kind":"grant","planned":false,"acquired":true,"shares":11904,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on September 1, 2024, one year anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units of which shares will be delivered to the reporting person upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on September 1, 2024, one year anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units of which shares will be delivered to the reporting person upon vesting."}],"balance_after":11904,"derivative":{"underlying":"Common Stock","underlying_shares":11904},"source":{"system":"sec-edgar","filing":"0000805928-23-000122","document":"wf-form4_169408287703094.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000122/wf-form4_169408287703094.xml","form_type":"4"}},{"id":1786369,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2023-09-07T10:34:48.000Z","date":"2023-09-01","kind":"grant","planned":false,"acquired":true,"shares":20436,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on September 1, 2024, one year anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units of which shares will be delivered to the reporting person upon vesting."}],"balance_after":20436,"derivative":{"exercise_price":6.3,"expiration_date":"2033-09-01","underlying":"Common Stock","underlying_shares":20436},"source":{"system":"sec-edgar","filing":"0000805928-23-000122","document":"wf-form4_169408287703094.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000122/wf-form4_169408287703094.xml","form_type":"4"}},{"id":1868341,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-05T22:24:29.000Z","date":"2023-06-01","kind":"exercise","planned":false,"acquired":false,"shares":6459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2023, one year from the anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2023, one year from the anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6459},"source":{"system":"sec-edgar","filing":"0000805928-23-000060","document":"wf-form4_168600385814712.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000060/wf-form4_168600385814712.xml","form_type":"4"}},{"id":1868340,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-05T22:24:29.000Z","date":"2023-06-01","kind":"exercise","planned":false,"acquired":true,"shares":6459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of restricted stock units that vested on June 1, 2023."}],"balance_after":70342,"source":{"system":"sec-edgar","filing":"0000805928-23-000060","document":"wf-form4_168600385814712.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000060/wf-form4_168600385814712.xml","form_type":"4"}},{"id":1892617,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-16T20:31:14.000Z","date":"2023-05-12","kind":"exercise","planned":false,"acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":8.57,"exercise_date":"2016-12-16","expiration_date":"2023-09-16","underlying":"Common Stock","underlying_shares":0},"source":{"system":"sec-edgar","filing":"0000805928-23-000053","document":"wf-form4_168426906043269.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000053/wf-form4_168426906043269.xml","form_type":"4"}},{"id":1892616,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-16T20:31:14.000Z","date":"2023-05-12","kind":"exercise","planned":false,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":8.57,"exercise_date":"2018-09-16","expiration_date":"2023-09-16","underlying":"Common Stock","underlying_shares":0},"source":{"system":"sec-edgar","filing":"0000805928-23-000053","document":"wf-form4_168426906043269.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000053/wf-form4_168426906043269.xml","form_type":"4"}},{"id":1892615,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-16T20:31:14.000Z","date":"2023-05-12","kind":"exercise","planned":false,"acquired":true,"shares":3750,"price":9.22,"value":34575.0,"ownership":{"direct":true},"balance_after":63883,"source":{"system":"sec-edgar","filing":"0000805928-23-000053","document":"wf-form4_168426906043269.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000053/wf-form4_168426906043269.xml","form_type":"4"}},{"id":1892614,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-16T20:31:14.000Z","date":"2023-05-12","kind":"exercise","planned":false,"acquired":true,"shares":25000,"price":9.22,"value":230500.0,"ownership":{"direct":true},"balance_after":60133,"source":{"system":"sec-edgar","filing":"0000805928-23-000053","document":"wf-form4_168426906043269.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000053/wf-form4_168426906043269.xml","form_type":"4"}},{"id":1905388,"issuer":{"id":1707,"kind":"organization","name":"BAXTER INTERNATIONAL INC","symbol":"BAX"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $1 par value","published_at":"2023-05-04T20:35:53.000Z","date":"2023-05-02","kind":"grant","planned":false,"acquired":true,"shares":4573,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant."}],"balance_after":17894,"source":{"system":"sec-edgar","filing":"0001062993-23-010216","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/10456/000106299323010216/form4.xml","form_type":"4"}},{"id":1957605,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2023-03-13T20:23:07.000Z","date":"2023-03-09","kind":"grant","acquired":true,"shares":4210,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options become exercisable on the date of the 2024 Annual Meeting of Stockholders."}],"balance_after":4210,"derivative":{"exercise_price":78.49,"expiration_date":"2033-03-09","underlying":"Common Stock","underlying_shares":4210},"source":{"system":"sec-edgar","filing":"0001127602-23-009879","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760223009879/form4.xml","form_type":"4"}},{"id":1957604,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-03-13T20:23:07.000Z","date":"2023-03-09","kind":"grant","acquired":true,"shares":1465,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units which vest on the date of the 2024 Annual Meeting of Stockholders and are settled in shares of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units are settled in shares of common stock on a one-for-one basis."}],"balance_after":19158,"source":{"system":"sec-edgar","filing":"0001127602-23-009879","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760223009879/form4.xml","form_type":"4"}},{"id":2246234,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-03T20:09:55.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":6459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2023, one year anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2023, one year anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units."}],"balance_after":6459,"derivative":{"underlying":"Common Stock","underlying_shares":6459},"source":{"system":"sec-edgar","filing":"0000805928-22-000065","document":"wf-form4_165428697291546.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592822000065/wf-form4_165428697291546.xml","form_type":"4"}},{"id":2246233,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2022-06-03T20:09:55.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":11811,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2023, one year anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units."}],"balance_after":11811,"derivative":{"exercise_price":9.29,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":11811},"source":{"system":"sec-edgar","filing":"0000805928-22-000065","document":"wf-form4_165428697291546.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592822000065/wf-form4_165428697291546.xml","form_type":"4"}},{"id":2246232,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-03T20:09:55.000Z","date":"2022-06-01","kind":"exercise","acquired":false,"shares":3036,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3036},"source":{"system":"sec-edgar","filing":"0000805928-22-000065","document":"wf-form4_165428697291546.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592822000065/wf-form4_165428697291546.xml","form_type":"4"}},{"id":2246231,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-03T20:09:55.000Z","date":"2022-06-01","kind":"exercise","acquired":true,"shares":3036,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of restricted stock units that vested on June 1, 2022."}],"balance_after":35133,"source":{"system":"sec-edgar","filing":"0000805928-22-000065","document":"wf-form4_165428697291546.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592822000065/wf-form4_165428697291546.xml","form_type":"4"}},{"id":2281643,"issuer":{"id":1707,"kind":"organization","name":"BAXTER INTERNATIONAL INC","symbol":"BAX"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $1 par value","published_at":"2022-05-05T21:27:06.000Z","date":"2022-05-03","kind":"grant","acquired":true,"shares":2706,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person received a grant of fully vested shares of common stock of Baxter International Inc. (BII), subject to the terms and conditions of the applicable grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The amount of securities beneficially owned include 42.90 shares acquired under the BII Dividend Reinvestment Plan (DRIP) between April 1, 2019 and April 1, 2021."}],"balance_after":13168,"source":{"system":"sec-edgar","filing":"0001062993-22-011693","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/10456/000106299322011693/form4.xml","form_type":"4"}},{"id":2336584,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2022-03-14T20:36:15.000Z","date":"2022-03-10","kind":"grant","acquired":true,"shares":5293,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options become exercisable on the date of the 2023 Annual Meeting of Stockholders."}],"balance_after":5293,"derivative":{"exercise_price":70.28,"expiration_date":"2032-03-10","underlying":"Common Stock","underlying_shares":5293},"source":{"system":"sec-edgar","filing":"0001127602-22-009149","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760222009149/form4.xml","form_type":"4"}},{"id":2336583,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-03-14T20:36:15.000Z","date":"2022-03-10","kind":"grant","acquired":true,"shares":1565,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units which vest on the date of the 2023 Annual Meeting of Stockholders and are settled in shares of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units are settled in shares of common stock on a one-for-one basis."}],"balance_after":17693,"source":{"system":"sec-edgar","filing":"0001127602-22-009149","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760222009149/form4.xml","form_type":"4"}},{"id":2684916,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-06-03T21:14:20.000Z","date":"2021-06-01","kind":"grant","acquired":true,"shares":3036,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units."}],"balance_after":3036,"derivative":{"underlying":"Common Stock","underlying_shares":3036},"source":{"system":"sec-edgar","filing":"0000805928-21-000111","document":"wf-form4_162275483321636.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000111/wf-form4_162275483321636.xml","form_type":"4"}},{"id":2684915,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2021-06-03T21:14:20.000Z","date":"2021-06-01","kind":"grant","acquired":true,"shares":6030,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units."}],"balance_after":6030,"derivative":{"exercise_price":19.76,"expiration_date":"2031-06-01","underlying":"Common Stock","underlying_shares":6030},"source":{"system":"sec-edgar","filing":"0000805928-21-000111","document":"wf-form4_162275483321636.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000111/wf-form4_162275483321636.xml","form_type":"4"}},{"id":2684914,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-06-03T21:14:20.000Z","date":"2021-06-01","kind":"exercise","acquired":false,"shares":6173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This reflects the number of restricted stock units that became vested as of June 1, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This reflects the number of restricted stock units that became vested as of June 1, 2021."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6173},"source":{"system":"sec-edgar","filing":"0000805928-21-000111","document":"wf-form4_162275483321636.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000111/wf-form4_162275483321636.xml","form_type":"4"}},{"id":2684913,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-03T21:14:20.000Z","date":"2021-06-01","kind":"exercise","acquired":true,"shares":6173,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":32097,"source":{"system":"sec-edgar","filing":"0000805928-21-000111","document":"wf-form4_162275483321636.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000111/wf-form4_162275483321636.xml","form_type":"4"}},{"id":2726173,"issuer":{"id":1707,"kind":"organization","name":"BAXTER INTERNATIONAL INC","symbol":"BAX"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-06T22:05:59.000Z","date":"2021-05-04","kind":"grant","acquired":true,"shares":5685,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received a grant of fully vested Company stock options, subject to the terms and conditions of the applicable grant."}],"balance_after":5685,"derivative":{"exercise_price":87.44,"expiration_date":"2031-05-04","underlying":"Common Stock, $1 par value","underlying_shares":5685},"source":{"system":"sec-edgar","filing":"0001400568-21-000001","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/10456/000140056821000001/edgar.xml","form_type":"4"}},{"id":2726172,"issuer":{"id":1707,"kind":"organization","name":"BAXTER INTERNATIONAL INC","symbol":"BAX"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $1 par value","published_at":"2021-05-06T22:05:59.000Z","date":"2021-05-04","kind":"grant","acquired":true,"shares":1116,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person received a grant of fully vested shares of common stock of Baxter International Inc. (\"Company\"), subject to the terms and conditions of the applicable grant."}],"balance_after":10365,"source":{"system":"sec-edgar","filing":"0001400568-21-000001","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/10456/000140056821000001/edgar.xml","form_type":"4"}},{"id":2790312,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2021-03-15T22:22:29.000Z","date":"2021-03-11","kind":"grant","acquired":true,"shares":5055,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option becomes exercisable on the date of the 2022 Annual Meeting of Stockholders."}],"balance_after":5055,"derivative":{"exercise_price":71.03,"expiration_date":"2031-03-11","underlying":"Common Stock","underlying_shares":5055},"source":{"system":"sec-edgar","filing":"0001127602-21-010632","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760221010632/form4.xml","form_type":"4"}},{"id":2790311,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-03-15T22:22:29.000Z","date":"2021-03-11","kind":"grant","acquired":true,"shares":1478,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units which vest on the date of the 2022 Annual Meeting of Stockholders and are settled in shares of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units are settled in shares of common stock on a one-for-one basis."}],"balance_after":16128,"source":{"system":"sec-edgar","filing":"0001127602-21-010632","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760221010632/form4.xml","form_type":"4"}},{"id":3037042,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-08T21:36:52.000Z","date":"2020-09-03","kind":"grant","acquired":true,"shares":2591,"price":11.75,"value":30444.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of restricted stock units that became vested as of September 3, 2020."}],"balance_after":25924,"source":{"system":"sec-edgar","filing":"0001179110-20-009634","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911020009634/edgar.xml","form_type":"4"}},{"id":3112551,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-06-12T20:22:40.000Z","date":"2020-06-01","kind":"grant","acquired":true,"shares":6173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"shares","element":"transactionShares","label":"F3","text":"The original Form 4, filed June 3, 2020, incorrectly stated the number of derivative securities (Column 5), the number of shares (Column 7) and number of derivatives securities beneficially owned following reported transaction (Column 9) for both the Stock Options and Restricted Stock Units. Footnote 1 has also been amended to reflect the accurate number of stock options and restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2021, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2021, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The original Form 4, filed June 3, 2020, incorrectly stated the number of derivative securities (Column 5), the number of shares (Column 7) and number of derivatives securities beneficially owned following reported transaction (Column 9) for both the Stock Options and Restricted Stock Units. Footnote 1 has also been amended to reflect the accurate number of stock options and restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The original Form 4, filed June 3, 2020, incorrectly stated the number of derivative securities (Column 5), the number of shares (Column 7) and number of derivatives securities beneficially owned following reported transaction (Column 9) for both the Stock Options and Restricted Stock Units. Footnote 1 has also been amended to reflect the accurate number of stock options and restricted stock units."}],"balance_after":6173,"derivative":{"underlying":"Common Stock","underlying_shares":6173},"source":{"system":"sec-edgar","filing":"0001179110-20-007283","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911020007283/edgar.xml","form_type":"4/A","original_submission_date":"2020-06-03"}},{"id":3112550,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2020-06-12T20:22:40.000Z","date":"2020-06-01","kind":"grant","acquired":true,"shares":12605,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The original Form 4, filed June 3, 2020, incorrectly stated the number of derivative securities (Column 5), the number of shares (Column 7) and number of derivatives securities beneficially owned following reported transaction (Column 9) for both the Stock Options and Restricted Stock Units. Footnote 1 has also been amended to reflect the accurate number of stock options and restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2021, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The original Form 4, filed June 3, 2020, incorrectly stated the number of derivative securities (Column 5), the number of shares (Column 7) and number of derivatives securities beneficially owned following reported transaction (Column 9) for both the Stock Options and Restricted Stock Units. Footnote 1 has also been amended to reflect the accurate number of stock options and restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The original Form 4, filed June 3, 2020, incorrectly stated the number of derivative securities (Column 5), the number of shares (Column 7) and number of derivatives securities beneficially owned following reported transaction (Column 9) for both the Stock Options and Restricted Stock Units. Footnote 1 has also been amended to reflect the accurate number of stock options and restricted stock units."}],"balance_after":12605,"derivative":{"exercise_price":9.72,"expiration_date":"2030-06-01","underlying":"Common Stock","underlying_shares":12605},"source":{"system":"sec-edgar","filing":"0001179110-20-007283","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911020007283/edgar.xml","form_type":"4/A","original_submission_date":"2020-06-03"}},{"id":3125661,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-06-03T21:02:24.000Z","date":"2020-06-01","kind":"grant","acquired":true,"shares":4115,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2021, one year from the anniversary of the grant date. Two-thirds of the annual equity grant value is in the form of non-qualified stock options and one-third of the annual equity grant value is in the form of restricted stock units."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2021, one year from the anniversary of the grant date. Two-thirds of the annual equity grant value is in the form of non-qualified stock options and one-third of the annual equity grant value is in the form of restricted stock units."}],"balance_after":4115,"derivative":{"underlying":"Common Stock","underlying_shares":4115},"source":{"system":"sec-edgar","filing":"0001179110-20-006910","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911020006910/edgar.xml","form_type":"4"}},{"id":3125660,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2020-06-03T21:02:24.000Z","date":"2020-06-01","kind":"grant","acquired":true,"shares":16807,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2021, one year from the anniversary of the grant date. Two-thirds of the annual equity grant value is in the form of non-qualified stock options and one-third of the annual equity grant value is in the form of restricted stock units."}],"balance_after":16807,"derivative":{"exercise_price":9.72,"expiration_date":"2030-06-01","underlying":"Common Stock","underlying_shares":16807},"source":{"system":"sec-edgar","filing":"0001179110-20-006910","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911020006910/edgar.xml","form_type":"4"}},{"id":3159082,"issuer":{"id":1707,"kind":"organization","name":"BAXTER INTERNATIONAL INC","symbol":"BAX"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-07T20:23:54.000Z","date":"2020-05-05","kind":"grant","acquired":true,"shares":5293,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received a grant of fully vested Company stock options, subject to the terms and conditions of the applicable grant."}],"balance_after":5293,"derivative":{"exercise_price":88.74,"expiration_date":"2030-05-03","underlying":"Common Stock, $1 par value","underlying_shares":5293},"source":{"system":"sec-edgar","filing":"0001400568-20-000002","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/10456/000140056820000002/edgar.xml","form_type":"4"}},{"id":3159081,"issuer":{"id":1707,"kind":"organization","name":"BAXTER INTERNATIONAL INC","symbol":"BAX"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $1 par value","published_at":"2020-05-07T20:23:54.000Z","date":"2020-05-05","kind":"grant","acquired":true,"shares":1099,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person received a grant of fully vested shares of common stock of Baxter International Inc. (\"Company\"), subject to the terms and conditions of the applicable grant."}],"balance_after":9249,"source":{"system":"sec-edgar","filing":"0001400568-20-000002","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/10456/000140056820000002/edgar.xml","form_type":"4"}},{"id":3201639,"issuer":{"id":1707,"kind":"organization","name":"BAXTER INTERNATIONAL INC","symbol":"BAX"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $1 par value","published_at":"2020-03-19T20:52:42.000Z","date":"2020-03-19","kind":"grant","acquired":true,"shares":1500,"price":79.94,"value":119910.0,"ownership":{"direct":true},"balance_after":8150,"source":{"system":"sec-edgar","filing":"0001400568-20-000001","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/10456/000140056820000001/edgar.xml","form_type":"4"}},{"id":3221461,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2020-03-09T21:09:49.000Z","date":"2020-03-05","kind":"grant","acquired":true,"shares":7322,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options become exercisable on the date of the 2021 Annual Meeting of Stockholders."}],"balance_after":7322,"derivative":{"exercise_price":47.36,"expiration_date":"2030-03-05","underlying":"Common Stock","underlying_shares":7322},"source":{"system":"sec-edgar","filing":"0001127602-20-009975","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760220009975/form4.xml","form_type":"4"}},{"id":3221460,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-03-09T21:09:49.000Z","date":"2020-03-05","kind":"grant","acquired":true,"shares":2217,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units which vest on the date of the 2021 Annual Meeting of Stockholders and are settled in shares of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units are settled in shares of common stock on a one-for-one basis."}],"balance_after":14650,"source":{"system":"sec-edgar","filing":"0001127602-20-009975","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760220009975/form4.xml","form_type":"4"}},{"id":3424085,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-09-04T22:21:57.000Z","date":"2019-09-03","kind":"grant","acquired":true,"shares":2591,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on September 3, 2019, one year from the anniversary of the grant date. Two-thirds of the annual equity grant value is in the form of non-qualified stock options and one-third of the annual equity grant value is in the form of restricted stock units."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on September 3, 2019, one year from the anniversary of the grant date. Two-thirds of the annual equity grant value is in the form of non-qualified stock options and one-third of the annual equity grant value is in the form of restricted stock units."}],"balance_after":2591,"derivative":{"underlying":"Common Stock","underlying_shares":2591},"source":{"system":"sec-edgar","filing":"0001179110-19-010094","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911019010094/edgar.xml","form_type":"4"}},{"id":3424084,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2019-09-04T22:21:57.000Z","date":"2019-09-03","kind":"grant","acquired":true,"shares":10710,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on September 3, 2019, one year from the anniversary of the grant date. Two-thirds of the annual equity grant value is in the form of non-qualified stock options and one-third of the annual equity grant value is in the form of restricted stock units."}],"balance_after":10710,"derivative":{"exercise_price":15.44,"expiration_date":"2029-09-03","underlying":"Common Stock","underlying_shares":10710},"source":{"system":"sec-edgar","filing":"0001179110-19-010094","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911019010094/edgar.xml","form_type":"4"}},{"id":3490577,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-14T20:31:49.000Z","date":"2019-06-13","kind":"purchase","acquired":true,"shares":5000,"price":20.25,"value":101250.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person purchased these shares in her individual capacity in the open market and not through any directed share or other formal program."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $20.20 to $20.26. The reporting person undertakes to provide to Axogen, Inc., any security holder of Axogen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":23333,"source":{"system":"sec-edgar","filing":"0001179110-19-007686","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911019007686/edgar.xml","form_type":"4"}},{"id":3534714,"issuer":{"id":1707,"kind":"organization","name":"BAXTER INTERNATIONAL INC","symbol":"BAX"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-09T20:15:15.000Z","date":"2019-05-07","kind":"grant","acquired":true,"shares":6138,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received a grant of fully vested Company stock options, subject to the terms and conditions of the applicable grant."}],"balance_after":6138,"derivative":{"exercise_price":76.69,"expiration_date":"2029-05-07","underlying":"Common Stock, $1 par value","underlying_shares":6138},"source":{"system":"sec-edgar","filing":"0001400568-19-000003","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/10456/000140056819000003/edgar.xml","form_type":"4"}},{"id":3534713,"issuer":{"id":1707,"kind":"organization","name":"BAXTER INTERNATIONAL INC","symbol":"BAX"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $1 par value","published_at":"2019-05-09T20:15:15.000Z","date":"2019-05-07","kind":"grant","acquired":true,"shares":1206,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person received a grant of fully vested shares of common stock of Baxter International Inc. (the \"Company\"), subject to the terms and conditions of the applicable grant."}],"balance_after":6650,"source":{"system":"sec-edgar","filing":"0001400568-19-000003","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/10456/000140056819000003/edgar.xml","form_type":"4"}},{"id":3600552,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2019-03-12T11:41:38.000Z","date":"2019-03-07","kind":"grant","acquired":true,"shares":6523,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options become exercisable on the date of the 2020 Annual Meeting of Stockholders"}],"balance_after":6523,"derivative":{"exercise_price":46.81,"expiration_date":"2029-03-07","underlying":"Common Stock","underlying_shares":6523},"source":{"system":"sec-edgar","filing":"0001127602-19-010917","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760219010917/form4.xml","form_type":"4"}},{"id":3600551,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-03-12T11:41:38.000Z","date":"2019-03-07","kind":"grant","acquired":true,"shares":2136,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units which vests on the date of the 2020 Annual Meeting of Stockholders and are settled in shares of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units are settled in shares of common stock on a one-for-one basis."}],"balance_after":12433,"source":{"system":"sec-edgar","filing":"0001127602-19-010917","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760219010917/form4.xml","form_type":"4"}},{"id":3648823,"issuer":{"id":1707,"kind":"organization","name":"BAXTER INTERNATIONAL INC","symbol":"BAX"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $1 par value","published_at":"2019-02-20T21:42:07.000Z","date":"2019-02-18","kind":"grant","acquired":true,"shares":444,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person received a grant of 444 fully vested shares of common stock of Baxter International Inc. subject to the terms and conditions of the applicable grant."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person received a grant of 444 fully vested shares of common stock of Baxter International Inc. subject to the terms and conditions of the applicable grant."}],"balance_after":5444,"source":{"system":"sec-edgar","filing":"0001400568-19-000002","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/10456/000140056819000002/edgar.xml","form_type":"4"}}],"next_cursor":"2019-02-20T21:42:07.000000Z,3648823"}